Viscoelastic properties of polymer mixtures containing micro-ribbons and microfibres for the 3D printing of pharmaceutical dosage forms by fused deposition modelling
Journal of Pharmacy and Pharmacology · 02.05.2026 · 78 (5)
DOI: 10.1093/jpp/rgag044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 06.05.2026. Verfasst von Marwan Algellay und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, Merseyside, United Kingdom. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Povidone, Polymers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To match the disintegration time of conventional oral films with 3D printed fast-dissolving oral films (FDFs), micro-composites have been used in the formulation. However, in certain cases the 3D-printer failed to produce desired films.
Methods
The viscoelastic properties were evaluated for polyvinyl alcohol and polyvinylpyrrolidone filaments containing chitosan micro-ribbons and cellulose microfibres as micro-composites with the hypothesis that intermittent nozzle blockage was the mechanism responsible for the observed printing failures. Key findings Domination of loss modulus over storage modulus was observed for successful printing. Micro-composites improved the viscoelastic properties of filaments including filaments that failed to print. The novelty of this research was that poor viscoelastic properties could not be accounted for the failure of FDF 3D printing for formulations with high micro-composite contents. Filaments of these formulations exhibited rough surfaces with visible aggregates. These observations suggested intermittent nozzle blockage by aggregated micro-composites could have been the cause of 3D printing failure. This hypothesis was supported by successful printing when printer nozzle diameter increased.
Conclusions
The domination of loss modulus over storage modulus was essential for filaments to achieve successful FDF 3D printing. However, micro-composites at high concentrations in the formulation may induced nozzle blockage leading to printing failures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, Merseyside, United Kingdom.
- Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, Merseyside, United Kingdom.
- Faculty of Health & Life Sciences, University of Liverpool, William Henry Duncan Building|6 West Derby Street, Liverpool L7 8TX, Merseyside, United Kingdom.
ORCID-Profile: Marwan Algellay, Matthew Roberts, Touraj Ehtezazi
Zitieren
APA
Algellay, M., Sarker, S. D., Roberts, M., Bosworth, L. A., & Ehtezazi, T. (2026). Viscoelastic properties of polymer mixtures containing micro-ribbons and microfibres for the 3D printing of pharmaceutical dosage forms by fused deposition modelling. Journal of Pharmacy and Pharmacology, 78(5). https://doi.org/10.1093/jpp/rgag044
Vancouver
Algellay M, Sarker SD, Roberts M, Bosworth LA, Ehtezazi T. Viscoelastic properties of polymer mixtures containing micro-ribbons and microfibres for the 3D printing of pharmaceutical dosage forms by fused deposition modelling. Journal of Pharmacy and Pharmacology. 2026;78(5). doi:10.1093/jpp/rgag044
BibTeX
@article{Algellay2026,
author = {Algellay, Marwan and Sarker, Satyajit D and Roberts, Matthew and Bosworth, Lucy A and Ehtezazi, Touraj},
title = {Viscoelastic properties of polymer mixtures containing micro-ribbons and microfibres for the 3D printing of pharmaceutical dosage forms by fused deposition modelling},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {5},
doi = {10.1093/jpp/rgag044}
}
EUVIMED